2nd Precision Medicine in Inflammatory Bowel Disease Hyatt Regency Boston, Boston

Not that much time has passed since our last summit. But a lot has changed. From 2023 to 2024, the industry has made unequivocal advances, from tangible progress using artificial intelligence to robust biomarker development, permitting precise prognosis, astute stratification, and meticulous patient monitoring. Unsurprisingly, this is reflected by countless recent approvals, IND filings, and new companies emerging out of stealth-mode.

In this context, the Precision Medicine in Inflammatory Bowel Disease Summit is returning for the second year, as the most comprehensive, ultra-specialized meeting. Uniting over 100 precision medicine in IBD experts, this summit will explore mind-blowing development that will fast-track the optimization of drug development and overcome the one-size-fits-all approach to medicine.